A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus.
A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus.
复制标题
双等位基因多核苷酸长度多态性解释了5p15.33前列腺癌风险基因座的功能因果关系。
DOI:
10.1038/s41467-023-40616-z
复制
发表时间:
2023-08-23
影响因子:
16.6
通讯作者:
Freedman, Matthew L.
中科院分区:
文献类型:
--
作者:
Spisak, Sandor;Tisza, Viktoria;Nuzzo, Pier Vitale;Seo, Ji-Heui;Pataki, Balint;Ribli, Dezso;Sztupinszki, Zsofia;Bell, Connor;Rohanizadegan, Mersedeh;Stillman, David R.;Alaiwi, Sarah Abou;Bartels, Alan B.;Papp, Marton;Shetty, Anamay;Abbasi, Forough;Lin, Xianzhi;Lawrenson, Kate;Gayther, Simon A.;Pomerantz, Mark;Baca, Sylvan;Solymosi, Norbert;Csabai, Istvan;Szallasi, Zoltan;Gusev, Alexander;Freedman, Matthew L.
To date, single-nucleotide polymorphisms (SNPs) have been the most intensively investigated class of polymorphisms in genome wide associations studies (GWAS), however, other classes such as insertion-deletion or multiple nucleotide length polymorphism (MNLPs) may also confer disease risk. Multiple reports have shown that the 5p15.33 prostate cancer risk region is a particularly strong expression quantitative trait locus (eQTL) for Iroquois Homeobox 4 (IRX4) transcripts. Here, we demonstrate using epigenome and genome editing that a biallelic (21 and 47 base pairs (bp)) MNLP is the causal variant regulating IRX4 transcript levels. In LNCaP prostate cancer cells (homozygous for the 21 bp short allele), a single copy knock-in of the 47 bp long allele potently alters the chromatin state, enabling de novo functional binding of the androgen receptor (AR) associated with increased chromatin accessibility, Histone 3 lysine 27 acetylation (H3K27ac), and ~3-fold upregulation of IRX4 expression. We further show that an MNLP is amongst the strongest candidate susceptibility variants at two additional prostate cancer risk loci. We estimated that at least 5% of prostate cancer risk loci could be explained by functional non-SNP causal variants, which may have broader implications for other cancers GWAS. More generally, our results underscore the importance of investigating other classes of inherited variation as causal mediators of human traits. Here, the authors functionally characterize a complex genetic variant relevant in prostate cancer that regulates IRX4 expression through epigenetic activation. This work highlights the significance of non-single nucleotide polymorphism causal variants in explaining disease risk.
登录
查看更多内容
影响因子:
2.7
作者:
Bruneau, BG;Bao, ZZ;Seidman, CE
通讯作者:
Seidman, CE
影响因子:
64.8
作者:
Buenrostro JD;Wu B;Litzenburger UM;Ruff D;Gonzales ML;Snyder MP;Chang HY;Greenleaf WJ
通讯作者:
Greenleaf WJ
影响因子:
30.8
作者:
Baca, Sylvan C.;Singler, Cassandra;Zacharia, Soumya;Seo, Ji-Heui;Morova, Tunc;Hach, Faraz;Ding, Yi;Schwarz, Tommer;Huang, Chia-Chi Flora;Anderson, Jacob;Fay, Andre P.;Kalita, Cynthia;Groha, Stefan;Pomerantz, Mark M.;Wang, Victoria;Linder, Simon;Sweeney, Christopher J.;Zwart, Wilbert;Lack, Nathan A.;Pasaniuc, Bogdan;Takeda, David Y.;Gusev, Alexander;Freedman, Matthew L.
通讯作者:
Freedman, Matthew L.
影响因子:
64.8
作者:
Ley, Timothy J.;Mardis, Elaine R.;Ding, Li;Fulton, Bob;McLellan, Michael D.;Chen, Ken;Dooling, David;Dunford-Shore, Brian H.;McGrath, Sean;Hickenbotham, Matthew;Cook, Lisa;Abbott, Rachel;Larson, David E.;Koboldt, Dan C.;Pohl, Craig;Smith, Scott;Hawkins, Amy;Abbott, Scott;Locke, Devin;Hillier, LaDeana W.;Miner, Tracie;Fulton, Lucinda;Magrini, Vincent;Wylie, Todd;Glasscock, Jarret;Conyers, Joshua;Sander, Nathan;Shi, Xiaoqi;Osborne, John R.;Minx, Patrick;Gordon, David;Chinwalla, Asif;Zhao, Yu;Ries, Rhonda E.;Payton, Jacqueline E.;Westervelt, Peter;Tomasson, Michael H.;Watson, Mark;Baty, Jack;Ivanovich, Jennifer;Heath, Sharon;Shannon, William D.;Nagarajan, Rakesh;Walter, Matthew J.;Link, Daniel C.;Graubert, Timothy A.;DiPersio, John F.;Wilson, Richard K.
通讯作者:
Wilson, Richard K.
影响因子:
16.6
作者:
Dadaev T;Saunders EJ;Newcombe PJ;Anokian E;Leongamornlert DA;Brook MN;Cieza-Borrella C;Mijuskovic M;Wakerell S;Olama AAA;Schumacher FR;Berndt SI;Benlloch S;Ahmed M;Goh C;Sheng X;Zhang Z;Muir K;Govindasami K;Lophatananon A;Stevens VL;Gapstur SM;Carter BD;Tangen CM;Goodman P;Thompson IM Jr;Batra J;Chambers S;Moya L;Clements J;Horvath L;Tilley W;Risbridger G;Gronberg H;Aly M;Nordström T;Pharoah P;Pashayan N;Schleutker J;Tammela TLJ;Sipeky C;Auvinen A;Albanes D;Weinstein S;Wolk A;Hakansson N;West C;Dunning AM;Burnet N;Mucci L;Giovannucci E;Andriole G;Cussenot O;Cancel-Tassin G;Koutros S;Freeman LEB;Sorensen KD;Orntoft TF;Borre M;Maehle L;Grindedal EM;Neal DE;Donovan JL;Hamdy FC;Martin RM;Travis RC;Key TJ;Hamilton RJ;Fleshner NE;Finelli A;Ingles SA;Stern MC;Rosenstein B;Kerns S;Ostrer H;Lu YJ;Zhang HW;Feng N;Mao X;Guo X;Wang G;Sun Z;Giles GG;Southey MC;MacInnis RJ;FitzGerald LM;Kibel AS;Drake BF;Vega A;Gómez-Caamaño A;Fachal L;Szulkin R;Eklund M;Kogevinas M;Llorca J;Castaño-Vinyals G;Penney KL;Stampfer M;Park JY;Sellers TA;Lin HY;Stanford JL;Cybulski C;Wokolorczyk D;Lubinski J;Ostrander EA;Geybels MS;Nordestgaard BG;Nielsen SF;Weisher M;Bisbjerg R;Røder MA;Iversen P;Brenner H;Cuk K;Holleczek B;Maier C;Luedeke M;Schnoeller T;Kim J;Logothetis CJ;John EM;Teixeira MR;Paulo P;Cardoso M;Neuhausen SL;Steele L;Ding YC;De Ruyck K;De Meerleer G;Ost P;Razack A;Lim J;Teo SH;Lin DW;Newcomb LF;Lessel D;Gamulin M;Kulis T;Kaneva R;Usmani N;Slavov C;Mitev V;Parliament M;Singhal S;Claessens F;Joniau S;Van den Broeck T;Larkin S;Townsend PA;Aukim-Hastie C;Gago-Dominguez M;Castelao JE;Martinez ME;Roobol MJ;Jenster G;van Schaik RHN;Menegaux F;Truong T;Koudou YA;Xu J;Khaw KT;Cannon-Albright L;Pandha H;Michael A;Kierzek A;Thibodeau SN;McDonnell SK;Schaid DJ;Lindstrom S;Turman C;Ma J;Hunter DJ;Riboli E;Siddiq A;Canzian F;Kolonel LN;Le Marchand L;Hoover RN;Machiela MJ;Kraft P;PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium;Freedman M;Wiklund F;Chanock S;Henderson BE;Easton DF;Haiman CA;Eeles RA;Conti DV;Kote-Jarai Z
通讯作者:
Kote-Jarai Z